| Item Name |
Product Image |
Price |
Narrower applicability than CHIRALPAK® AGP. Separates preferentially weak and strong acids and non-protolytic compounds. The chiral selector in this stationary phase is human serum albumin (HSA). The protein has been immobilized onto spherical... |
 |
... more info
|
Narrower applicability than CHIRALPAK® AGP. Separates preferentially weak and strong acids and non-protolytic compounds. The chiral selector in this stationary phase is human serum albumin (HSA). The protein has been immobilized onto spherical... |
|
... more info
|
Narrower applicability than CHIRALPAK® AGP. Separates preferentially weak and strong acids and non-protolytic compounds. The chiral selector in this stationary phase is human serum albumin (HSA). The protein has been immobilized onto spherical... |
|
... more info
|
Narrower applicability than CHIRALPAK® AGP. Separates preferentially weak and strong acids and non-protolytic compounds. The chiral selector in this stationary phase is human serum albumin (HSA). The protein has been immobilized onto spherical... |
|
... more info
|
Narrower applicability than CHIRALPAK® AGP. Separates preferentially weak and strong acids and non-protolytic compounds. The chiral selector in this stationary phase is human serum albumin (HSA). The protein has been immobilized onto spherical... |
|
... more info
|
Narrower applicability than CHIRALPAK® AGP. Separates preferentially weak and strong acids and non-protolytic compounds. The chiral selector in this stationary phase is human serum albumin (HSA). The protein has been immobilized onto spherical... |
|
... more info
|
Narrower applicability than CHIRALPAK® AGP. Separates preferentially weak and strong acids and non-protolytic compounds. The chiral selector in this stationary phase is human serum albumin (HSA). The protein has been immobilized onto spherical... |
|
... more info
|
Narrower applicability than CHIRALPAK® AGP. Separates preferentially weak and strong acids and non-protolytic compounds. The chiral selector in this stationary phase is human serum albumin (HSA). The protein has been immobilized onto spherical... |
|
... more info
|
Narrower applicability than CHIRALPAK® AGP. Separates preferentially weak and strong acids and non-protolytic compounds. The chiral selector in this stationary phase is human serum albumin (HSA). The protein has been immobilized onto spherical... |
|
... more info
|
10mm, 4mm 5um Narrower applicability than CHIRALPAK® AGP. Separates preferentially weak and strong acids and non-protolytic compounds. The chiral selector in this stationary phase is human serum albumin (HSA). The protein has been immobilized... |
|
... more info
|
10mm, 3mm 5um Narrower applicability than CHIRALPAK® AGP. Separates preferentially weak and strong acids and non-protolytic compounds. The chiral selector in this stationary phase is human serum albumin (HSA). The protein has been immobilized... |
|
... more info
|
10mm, 2mm 5um Narrower applicability than CHIRALPAK® AGP. Separates preferentially weak and strong acids and non-protolytic compounds. The chiral selector in this stationary phase is human serum albumin (HSA). The protein has been immobilized... |
|
... more info
|
Narrower applicability than CHIRALPAK® AGP. Separates preferentially weak and strong acids and non-protolytic compounds. The chiral selector in this stationary phase is human serum albumin (HSA). The protein has been immobilized onto spherical... |
|
... more info
|
Narrower applicability than CHIRALPAK® AGP. Separates preferentially weak and strong acids and non-protolytic compounds. The chiral selector in this stationary phase is human serum albumin (HSA). The protein has been immobilized onto spherical... |
|
... more info
|
